Comorbidity

Related by string. comorbidity * * Charlson Comorbidity Index . Charlson comorbidity index . psychiatric comorbidity . National Comorbidity Survey . Comorbidity Study *

Related by context. All words. (Click for frequent words.) 71 Posttraumatic stress disorder 69 Neurocognitive 69 Depressive Symptoms 69 Heritability 68 Psychiatric Disorders 68 Pharmacologic 67 Comorbidities 67 SF #v# 67 Comorbid 67 comorbid anxiety 66 GH deficiency 66 subscale scores 66 depressive symptomatology 66 affective disorders 66 psychiatric comorbidity 66 Symptom Checklist 66 Adverse Event 66 Correlates 66 et al #a 66 Main Outcome Measure 65 abdominal adiposity 65 Clinical Outcome 65 Orthostatic Hypotension 65 Abnormal Involuntary Movement 65 comorbid disorders 65 Anxiety Depression 65 et al #b 65 comorbid depression 65 Risk Stratification 65 interobserver 65 Hippocampal 65 Main Outcome Measures 65 Diagnostic Criteria 65 Sociodemographic 65 Nemeroff CB 65 Heterogeneity 64 Symptom severity 64 Univariate 64 Neuroticism 64 psychiatric morbidity 64 alexithymia 64 IPAH 64 somatization disorder 64 EQ 5D 64 Health Assessment Questionnaire 64 Psychotic Disorders 64 Nonalcoholic Fatty Liver Disease 64 histological subtype 64 polyarticular 64 Outcome Measures 64 Rheumatoid 64 Gunderson JG 64 Juvenile Idiopathic Arthritis 64 Cognitive behavioral 63 Randomized Controlled Trials 63 comorbidity 63 schizophrenia schizoaffective disorder 63 Patellofemoral 63 Ischemic 63 CORE OM 63 Cardiotoxicity 63 Chronic Heart Failure 63 cognitive affective 63 Symptom Severity 63 Neuropsychiatric 63 Intervention Trial 63 atherothrombotic disease 63 Catheter Associated 63 Diabetic Foot Ulcer 63 See CLINICAL PHARMACOLOGY 63 #:#-# [037] 63 colorectal adenoma 63 Child Behavior Checklist 63 somatoform disorders 63 Meta Analysis 63 affective psychosis 63 Neurobehavioral 63 somatic symptoms 63 Mood disorders 63 meta regression 63 Hemodynamic 63 psychosocial variables 63 Genetic Variation 63 autonomic dysfunction 63 poststroke 63 #:#-# [023] 63 Ischaemic 63 Rosenheck RA 63 Adult ADHD 62 sociodemographic characteristics 62 Chronic Renal Failure 62 Differential Diagnosis 62 univariate 62 Suicidality 62 aminotransferase 62 Psychiatric Illness 62 Psychological Distress 62 impaired glucose metabolism 62 Generalized Anxiety Disorder 62 J Clin Oncol 62 gene polymorphisms 62 Ocular Surface Disease 62 Neuropsychological 62 chronicity 62 shorter telomere length 62 Antipsychotic 62 T2DM 62 multiple linear regression 62 multivariate analyzes 62 Determinants 62 SSc 62 Laryngeal Cancer 62 Cognitive Impairment 62 affective psychoses 62 clinicopathological 62 #:#-# [031] 62 Etiology 62 Thalamus 62 comorbid psychiatric disorders 62 Functional Assessment 62 Dissociation 62 HRQOL 62 Eds. 62 Kendler KS 62 Subtypes 62 Hypertrophy 62 Vertebral Fractures 62 psychometric properties 62 Suicidal Ideation 62 autoimmune thyroid 62 Schizoaffective Disorder 62 Brief Psychiatric 62 erection hardness 62 Assessment Questionnaire 62 J Consult Clin 62 premorbid 62 #:#-#,# CrossRef Medline [002] 62 Patients Receiving 62 Levels Linked 62 Functional Outcomes 62 extrapyramidal symptoms 62 promoter polymorphism 62 euthymic patients 62 Prefrontal 62 Stress Induced 62 Nonadherence 62 Exacerbation 62 Posttraumatic 62 Treating Chronic 62 Myocardial Perfusion 62 Conduct Disorder 62 Electroencephalography 62 mania hypomania 62 Valvular 62 bivariate analyzes 62 CYP #D# 62 univariate analyzes 62 Hypertrophic 62 #-# Full Text 62 Acute Decompensated Heart Failure 62 subclinical atherosclerosis 61 J Clin 61 Subarachnoid hemorrhage 61 JM et al 61 Non Alcoholic Steatohepatitis 61 Sleep Disturbance 61 Pharmacodynamics 61 #:#-# [029] 61 Myocardial Ischemia 61 multivariate Cox 61 Hyperlipidemia 61 APOE genotype 61 Treatment Outcome 61 subscores 61 Electrophysiological 61 Secondary Hyperparathyroidism 61 Depressive symptoms 61 chronic renal insufficiency 61 prolactin elevation 61 Disord 61 transcranial Doppler ultrasound 61 gallstone disease 61 Dysplasia 61 Suicidal Behavior 61 Autistic Disorder 61 neuropathologic 61 #q# deletion syndrome 61 et al Prevalence 61 leukocyte counts 61 Renal dysfunction 61 Depression Inventory 61 suicide attempters 61 HIV HCV coinfected 61 Eur Urol 61 Cognitive impairment 61 Selective serotonin reuptake inhibitors 61 rs# [004] 61 Psychopathy 61 Arch Neurol 61 multiple logistic regression 61 Cognitive Dysfunction 61 Ectopic 61 Predict Response 61 By Peggy Bresnick 61 hepatic insufficiency 61 allele frequencies 61 Ischemic Stroke 61 neurocognitive function 61 Arrhythmogenic 61 diabetic polyneuropathy 61 bivariate 61 Skeletal Muscle 61 Hepatic Encephalopathy 61 Inflammatory Pain 61 hyperhomocysteinemia 61 Cognitive Deficits 61 Relapsing Remitting Multiple Sclerosis 61 Meta Analyses 61 Nonalcoholic fatty liver 61 psychiatric comorbidities 61 multivariable analysis 61 familial aggregation 61 Short Stature 61 Montgomery Åsberg Depression 61 behavioral disinhibition 61 Am J Cardiol 61 Psychiatric Epidemiology 61 Prognostic Factors 61 Arthritis Rheum 61 unstable angina pectoris 61 Bone Metastases 61 JA et al 61 Thrombotic 61 Prognostic Value 61 nonpsychotic 61 Framingham Offspring 61 Cognitive Function 61 Relapsing Multiple Sclerosis 61 #:# -# [004] 61 J Nutr 61 Atopic Dermatitis 61 Arch Intern Med 61 Unstable Angina 61 Polymorphism 61 clinicopathological features 61 overactive bladder symptoms 61 ST Segment Elevation 61 Index CDAI 61 Endocrinol 61 Exacerbations 61 Hepatotoxicity 61 neuropsychological assessment 61 Coronary Artery Bypass Graft 61 BMI z 61 neurocognitive deficits 60 HRQoL 60 Glycemic Control 60 Neuroprotection 60 Subclinical 60 Fracture Risk 60 logistic regression analysis 60 Growth Hormone Deficiency 60 Gene Linked 60 Weissman MM 60 electrophysiologic 60 Dysregulation 60 Adjunctive 60 logistic regression model 60 Cerebellar 60 McGlashan TH 60 STEP BD 60 Bioavailability 60 neurocognition 60 Neuroleptic 60 Shows Promise Against 60 hematological parameters 60 Severe Asthma 60 Univariate analysis 60 Depressive Disorder 60 State Trait Anxiety 60 longitudinal cohort study 60 induce orthostatic hypotension 60 Symptom Scale 60 Liver Failure 60 euthymic 60 Thromboembolic 60 PsA 60 HRQL 60 clinicopathologic 60 Histological 60 Social Phobia 60 Systemic Lupus Erythematosus 60 venous thromboembolic disease 60 Affective Disorders 60 Self Efficacy 60 Adiposity 60 Willett WC 60 Clinical Efficacy 60 Histologic 60 Apolipoprotein E 60 anthropometric measures 60 STRATEGY FOR AN OPEN 60 Antiviral Therapy 60 Research www. elsevier.com 60 carotid IMT 60 Hypercholesterolemia 60 Poisson regression 60 Systemic Lupus Erythematosus SLE 60 diabetes mellitus hypertension 60 proton MR spectroscopy 60 Depressive Disorders 60 preoperative PSA 60 Leukemias 60 Lung Injury 60 Dehydrogenase 60 Magnetic Stimulation 60 pretransplant 60 differential gene expression 60 antiphospholipid syndrome 60 fasting plasma 60 meta analytic review 60 diabetes mellitus DM 60 syndromal 60 Interpersonal psychotherapy 60 Demonstrates Positive 60 comorbid conditions 60 Randomized controlled 60 Visual Analogue Scale VAS 60 NIH CPSI 60 Prognostic significance 60 Fibromyalgia Impact Questionnaire 60 Charlson Comorbidity Index 60 headache abdominal pain 60 HADS 60 Pelvic Organ Prolapse 60 hypothalamic pituitary adrenal axis 60 ECLS 60 Cortical 60 Sleep Disturbances 60 untreated psychosis 60 haematologic 60 Neurodevelopmental 60 Paroxysmal 60 Neurobiological 60 subscales 60 Prospective Cohort Study 60 #:#-# [025] 60 Proteinuria 60 J Am Coll 60 Autoantibodies 60 Free Full Text 60 Prolongs Survival 60 Clinician Administered PTSD 60 Venous thromboembolism 60 Kidney Function 60 tryptophan depletion 60 longitudinal observational study 60 Hypothalamic 60 Controlled Trial 60 variceal bleeding 60 Crohn Disease Activity 60 Adenoma 60 Int J 60 Psychiatric disorders 60 #:# -# [003] 60 Rheumatic 60 Thrombocytopenia 60 ACER paper 60 Malformations 60 Sexual Desire 60 Prospective Multicenter 60 depressive symptom 60 arterial calcification 60 multivariable adjusted 60 juvenile idiopathic arthritis 60 J Am Acad 60 pathophysiological mechanisms 60 left ventricular diastolic 60 Screening Questionnaire 60 multisystemic 60 schizophreniform disorder 60 periprocedural MI 60 WAIS III 60 Functional neuroimaging 60 Neuropathic 60 International Prognostic Scoring 60 descending thoracic 59 Sexual Satisfaction 59 Serum concentrations 59 intraobserver 59 Asymptomatic 59 logistic regression analyzes 59 artery stenosis 59 acute subacute 59 Thiazolidinediones 59 Menstrual Pain 59 T1DM 59 Decompensated Heart Failure 59 PON1 activity 59 Cerebral Cortex 59 posterior cingulate 59 Lower Limb 59 Depression Anxiety 59 Antidepressants Linked 59 neurocognitive functioning 59 Female Sexual Function 59 lipid elevations 59 Metabolic Disorder 59 Neurophysiological 59 Diastolic Heart Failure 59 Extracellular Matrix 59 Cognitive Problems 59 Arrhythmias 59 Colditz GA 59 atrophic gastritis 59 covariate 59 μg liter 59 TEAEs 59 Insulin sensitivity 59 thyrotropin levels 59 conducted retrospective cohort 59 LUTS 59 Idiopathic 59 convergent validity 59 Differential diagnosis 59 hypertension diabetes mellitus 59 Treatment Resistant 59 experimental allergic encephalomyelitis 59 Heart Failure Patients 59 % CI #.#-#.# [005] 59 Systematic Review 59 Korsakoff syndrome 59 symptomatic VTE 59 Showed Significant 59 histologic subtype 59 comorbid 59 serum estradiol 59 Kannel WB 59 nonalcoholic steatohepatitis 59 Echocardiographic 59 Polymorphisms 59 Escitalopram 59 Califf RM 59 Mechanistic 59 Hemorrhagic Stroke 59 susceptibility locus 59 Charlson comorbidity index 59 Prophylactic Treatment 59 subscore 59 Bulimia Nervosa 59 Preoperative 59 Interpersonal Psychotherapy 59 Clinical Relevance 59 ABCB1 59 somatostatin analog 59 Glucose Metabolism 59 prospective longitudinal 59 lymphoproliferative disorders 59 Subgroup Analysis 59 Improves Outcomes 59 See WARNINGS 59 Socio demographic 59 bipolar affective disorder 59 Adenomas 59 Estrogen Receptor 59 J Am Soc 59 Braunwald E. 59 Phenotypic 59 internalizing disorders 59 nontraumatic 59 Renal Insufficiency 59 HOMA IR 59 myeloproliferative neoplasms 59 symptomatology 59 Psychodynamic 59 syndromic 59 nondemented 59 neuropsychological functioning 59 Predictors 59 Skin sterol 59 hyperammonemia 59 intraventricular hemorrhage 59 N Engl J 59 Dyspnea 59 pharmacodynamic parameters 59 Systemic Sclerosis 59 Appelbaum PS 59 Subgroup analysis 59 Severe Primary IGFD 59 Depression Scale 59 Observational Study 59 Tumor Response 59 Nephrol 59 antiphospholipid antibodies 59 catechol O methyltransferase 59 Rheumatoid Arthritis Patients 59 mammographic density 59 MMSE score 59 Non Alcoholic Fatty 59 anticholinergic agents 59 Nocturia 59 J Pediatr 59 Psychosomatic Research 59 Long Term Efficacy 59 Genetic Markers 59 psychiatric outpatients 59 Alzheimer Disease Assessment 59 echocardiographic parameters 59 Suicidal ideation 59 Randomized Controlled Trial 59 neurocognitive impairment 59 glucocorticoid induced 59 Bipolar Mania 59 Mental Disorders DSM IV 59 Prevalence 59 Cardiorespiratory fitness 59 WCST 59 Chemotherapy induced 59 Knee Osteoarthritis 59 Dyslipidemia 59 Rhinosinusitis 59 Mild Cognitive Impairment 59 nondiabetic patients 59 moderate hepatic impairment 59 Neuroendocrine Tumors 59 Negative Symptoms 59 bacterial prostatitis 59 variant rs# 59 Schizophrenia Treatment 59 Apolipoprotein B 59 perioperative complications 59 Neuroanatomy 59 Cancer Res 59 Multivariate analysis 59 etiologic 59 NIDDM 59 hyperreflexia 59 Rating Scale BPRS 59 Septic Shock 59 atherothrombotic 59 Acute Coronary Syndromes 59 airway hyperresponsiveness 59 Hemodialysis Patients 59 neuropsychiatric diseases 59 Major depressive disorder 59 Effective Treatments 59 prostate cancer CaP 59 Distress Scale 59 somatization 59 Myelodysplastic Syndrome 59 Scale Revised 59 Inflammatory Markers 59 Somnolence 59 Mortality Risk 59 JE et al 59 Cytogenetic 59 Hypotension 59 Arterial Disease 59 Carotid Stenting 59 Major Depressive Disorder 59 waist circumference WC 59 osteoporotic vertebral fractures 59 Gender Differences 59 Molecular Basis 59 Cardiovascular Outcomes 59 corticosteroid induced 59 imipramine Tofranil 59 neuroleptic 59 Endothelial dysfunction 59 Intervention Effectiveness 59 pharmacologic treatments 58 carotid atherosclerosis 58 Predisposition 58 Clinical Practice Guideline 58 Hypogonadism 58 Inflammatory Arthritis 58 Insulin Resistance 58 Panic Disorder 58 fluoxetine Prozac 58 Drug Prevents 58 JL et al 58 bullous 58 Plaque Psoriasis 58 DSM IV Axis 58 Meta analyzes 58 YMRS 58 Phenotype 58 elevated transaminases 58 hypovitaminosis D 58 Prostatic 58 Pediatric Patients 58 #:#-# [028] 58 Prostate Px + 58 Lowers Risk 58 Overactive Bladder 58 Elderly Patients 58 Appears Safe 58 receptor antagonism 58 Functional Capacity 58 Clin J 58 Randomized Evaluation 58 Neurol 58 neuropathological 58 β blockers 58 Ventricular Tachycardia 58 onset diabetes mellitus 58 Logistic regression 58 postoperative delirium 58 Brief Pain 58 symptom severity 58 Akathisia 58 Myocardial Infarction 58 PLMs 58 aspartate aminotransferase AST 58 AST ALT 58 Multivariate 58 hemodynamic measurements 58 Mitral Regurgitation 58 Dilated Cardiomyopathy 58 #:#-# [035] 58 Peripheral Arterial 58 Myeloid 58 fluoxetine paroxetine 58 Exposure Linked 58 DAS# scores 58 Iron Deficiency Anemia 58 prefrontal cortical 58 #F FDG PET 58 Outcomes Study 58 Jeste DV 58 Epithelial Cell 58 tricyclic antidepressants TCAs 58 paroxetine sertraline 58 plasma leptin 58 Patency 58 Relieve Depression 58 CLINICAL PHARMACOLOGY 58 Hypertriglyceridemia 58 Iron Deficiency 58 Prevalence Estimates 58 Acute Physiology 58 Deyo RA 58 Complicated Grief 58 Blepharospasm 58 comorbid substance 58 Bosentan 58 Related Mortality 58 HAQ DI 58 Endothelial 58 Double Blind Randomized 58 #:#-# [007] 58 serum leptin 58 MLH1 58 Intravenous immunoglobulin 58 SELENA SLEDAI 58 neuritic 58 Bronchiectasis 58 Clinical Significance 58 Fecal Incontinence 58 Psychiatric Diagnosis 58 prospectively evaluated 58 Reduces Mortality 58 Parkinson Disease PD 58 Rating Scale MADRS 58 Cognitive dysfunction 58 esophageal carcinoma 58 Prospective Randomized 58 bronchial hyperresponsiveness 58 Pregnancy Outcomes 58 Prehypertension 58 Thymic 58 Socioeconomic status 58 Kruskal Wallis test 58 Atypical antipsychotics 58 J Neurosurg 58 LPS induced 58 Morphological 58 renal artery stenosis 58 predictive validity 58 Follicular Lymphoma 58 Adrenal 58 thyroid dysfunction 58 QIDS SR 58 Lymphoid 58 Myocardial Perfusion Imaging 58 congenital deficiency 58 serum lipid levels 58 inversely associated 58 Hyperphosphatemia 58 Score TOS 58 albumin excretion rate 58 hyper IgE syndrome 58 acetabular dysplasia 58 Sonographic 58 Inhibitory 58 neuroanatomical 58 psychosocial functioning 58 Psychological Stress 58 clinico pathological 58 Soft Tissue Sarcoma 58 Modifiable 58 nonfatal MI 58 Subtype 58 observational cohort study 58 tic disorders 58 FOR AN OPEN 58 insulin resistance syndrome 58 Prognostic 58 subtrochanteric 58 Hyperparathyroidism 58 metabolite concentrations 58 Impulsivity 58 neuropsychiatric symptoms 58 thiopurine 58 Hematopoietic 58 aldosterone antagonist 58 diabetes dyslipidemia 58 Behavioral Neurology 58 Osteoporotic Fractures 58 Accessed #/#/# [001] 58 ß blockers 58 Services #:#-#,# Abstract 58 thrombophilia 58 Pharmacotherapy 58 Neuropsychiatric Inventory 58 Neurogenic 58 Insulin Therapy 58 Dementia Diagnosis 58 inflammatory demyelinating 58 parietal cortices 58 Hyperkalemia 58 Erythropoietic 58 visceral adiposity 58 venlafaxine Effexor 58 Decompensated 58 thrombocytosis 58 nonbacterial prostatitis 58 Primary Biliary Cirrhosis 58 Depression Inventory BDI 58 Anti Tumor 58 salivary cortisol 58 Orally Active 58 autosomal recessive genetic 58 chronic myocardial ischemia 58 Chemotherapeutic Agents 58 Sjögren syndrome 58 Polypharmacy 58 Hospitalized Patients 58 preoperative diagnosis 58 Reperfusion Injury 58 Atomoxetine 58 pain subscale 58 meta analytic 58 Pain Rating Scale 58 Disease Activity 58 antiplatelet medications 58 HER2 overexpression 58 Mania Rating Scale 58 Non inferiority 58 cortical atrophy 58 prognostic indicators 58 Progenitor Cells 58 gene polymorphism 58 Assessment Scale 58 Bacteremia 58 urinary cortisol 58 Significantly Reduces 58 Postmenopausal Women 58 Cognitive Abilities 58 OSAHS 58 multivariable Cox 58 comorbid psychiatric 58 Dental caries 58 Infarction 58 Antisocial personality 58 Cardiovascular Risk Factors 58 tic severity 58 Combination Treatment 58 HLA DR4 58 Neurodegenerative 58 recurrent DVT 58 Beta Blockers 58 Parkin DM 58 J Child Adolesc 58 sertraline Zoloft 58 Systematic Treatment 58 FDG PET imaging 58 chi squared 58 leiomyomas 58 dysthymic disorder 58 nonfasting triglyceride levels 58 #:#-# [002] 58 Neurogenesis 58 Primary endpoints 58 Antisocial Personality Disorder 58 voiding dysfunction 58 Therapy Shows Promise 58 Renal Artery 58 hyperalgesia 58 adverse perinatal 58 Neoplasms 58 univariate analysis 58 Inventory BPI 58 Benign Prostatic Hyperplasia 58 lysosomal storage disease 58 Hematologic 58 Kupfer DJ 58 HOXB# 58 prospective multicentre 58 dyslipidaemia 58 Intervention Effectiveness CATIE 58 atherothrombosis 58 contrast echocardiography 58 tumor histology 58 Myelodysplastic Syndrome MDS 58 Haptoglobin 58 epididymitis 58 Therapeutic Intervention 58 Immunomodulatory 58 confounder 58 Charney DS 58 antiepileptics 58 Endothelial Function 58 postoperative AF 58 Histopathologic 58 Orthostatic hypotension 57 Severe Sepsis 57 Index FSFI 57 Ziprasidone 57 Immunologic 57 Papillary 57 hematopoietic cancers 57 Glomerular Filtration Rate 57 serum retinol 57 Inhibin B 57 Hyperuricemia 57 NPM1 mutation 57 urothelial carcinoma 57 Helps Relieve 57 Adenocarcinoma 57 Posttraumatic Stress 57 carotid stenosis 57 Malignancies 57 substance induced psychosis 57 Treated Patients 57 Modulates 57 levodopa induced 57 Multivariate logistic regression 57 Valvular Heart Disease 57 J Virol 57 sociodemographic factors 57 Susceptibility 57 Acute Stroke 57 hypercalciuria 57 lipid lowering agents 57 NMIBC 57 Psychol 57 Stent thrombosis 57 bronchoalveolar lavage BAL 57 Intracerebral Hemorrhage 57 Prostate Cancer Recurrence 57 methylenetetrahydrofolate reductase 57 Heart Rate Variability 57 Aripiprazole 57 Clinical Outcomes 57 Treating Depression 57 Wechsler Adult 57 Antiangiogenic 57 Atypical Hemolytic Uremic Syndrome 57 CrossRef Medline 57 serum BDNF 57 haloperidol Haldol 57 ANCOVA 57 Postural 57 electroencephalographic 57 Acute Treatment 57 Eye Diseases 57 AUDs 57 cytomegalovirus infection 57 bioavailable testosterone 57 multivariate logistic regression 57 myopathies 57 dermatologic reactions 57 laterality 57 Cardiac Rhythm 57 Chronic Insomnia 57 autoimmune thyroiditis 57 1 diabetes T1D 57 Dyspepsia 57 STRIDE PD 57 Antigen Specific 57 Nat Genet 57 Alcohol Dependence 57 HeFH 57 Coronary CTA 57 prognostic significance 57 Heterozygous Familial Hypercholesterolemia 57 pressure natriuresis 57 Bisphosphonate 57 hepatic cirrhosis 57 Crit Rev 57 neuroimaging studies 57 Postoperative 57 Am J Clin 57 daytime somnolence 57 posttreatment 57 dysthymia 57 J Clin Endocrinol Metab 57 nerve conduction velocity 57 Electrical Stimulation 57 Hormone Replacement 57 Psychometric 57 liver histology 57 Tasigna prolongs 57 Hepatic 57 FACIT 57 channelopathies 57 induced akathisia 57 Gestational Diabetes 57 hereditary hemochromatosis 57 Eisenmenger syndrome 57 Preterm Birth 57 inflammatory biomarkers 57 vasomotor 57 angiographically 57 Claudication 57 emotional lability 57 Nesiritide 57 Transcriptome 57 urolithiasis 57 Low Incidence 57 Combo Therapy 57 ADCS CGIC 57 puerperal psychosis 57 systolic hypertension 57 Urogenital 57 Glucocorticoids 57 nonvertebral fractures 57 Montgomery Asberg Depression 57 cerebral oxygenation 57 tissue oxygenation 57 vascular reactivity 57 CIMZIA TM certolizumab pegol 57 Slow Progression 57 phospholipase A2 57 Insulin Sensitivity 57 citalopram Celexa 57 adiponectin concentrations 57 Kessler RC 57 plasma cortisol 57 urate oxidase 57 Often Misdiagnosed 57 Appropriateness Criteria 57 generalized estimating 57 nonadherence 57 glycaemia 57 prospective multicenter study 57 glycosylated hemoglobin HbA1c 57 ASIA Impairment 57 chronic thromboembolic pulmonary 57 Renal Disease 57 Antipsychotic Drug 57 NIHSS score 57 inhibin B 57 convulsive disorders 57 #:#-# [001] 57 endophenotypes 57 Respiratory Distress 57 elevated fasting glucose 57 Interstitial cystitis 57 demyelinating 57 gastric cardia 57 pT 57 ABL1 57 Mindfulness Based Cognitive Therapy 57 metabolic dysfunction 57 Infect Dis 57 enthesitis 57 Shows Efficacy 57 Stratification 57 Degenerative Disc Disease 57 Stromal 57 Prevent Stroke 57 pairwise comparisons 57 Y BOCS 57 Non Responders 57 SGRQ 57 gait disturbance 57 calcaneal fractures 57 opioid naive 57 #:#-# [018] 57 Sarcopenia 57 QoL 57 MDRD 57 Hepatitis C Genotype 57 Childhood Trauma 57 β thalassemia 57 Sleep disordered breathing 57 Oral Fingolimod

Back to home page